Senescence-accelerated mouse (SAM): a biogerontological resource in aging research
暂无分享,去创建一个
[1] P. Jansen-Dürr,et al. Diseases of aging. , 2000, Vaccine.
[2] A. Morley,et al. Accelerated accumulation of somatic mutations in the senescence-accelerated mouse , 1998, Nature Genetics.
[3] A. Parfitt,et al. Increased Adipogenesis and Myelopoiesis in the Bone Marrow of SAMP6, a Murine Model of Defective Osteoblastogenesis and Low Turnover Osteopenia , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] M. Hosokawa,et al. Pathobiology of the senescence-accelerated mouse (SAM) , 1997, Experimental Gerontology.
[5] M. Kishikawa,et al. Herbal medicine and the study of aging in senescence-accelerated mice (SAMP1TA/Ngs) , 1997, Experimental Gerontology.
[6] D. Butterfield,et al. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-α-phenylnitrone , 1997 .
[7] M. Chung,et al. Oxidative status in senescence-accelerated mice. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.
[8] T. Takeda. [Senescence-accelerated mouse (SAM): with special reference to age-associated pathologies and their modulation]. , 1996, Nihon eiseigaku zasshi. Japanese journal of hygiene.
[9] A. Parfitt,et al. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. , 1996, The Journal of clinical investigation.
[10] D. Harrison. The SAM model of senescence Edited by Toshio Takeda, Elsevier Science B. V., P. O. Box 211, 1000 AE Amsterdam, The Netherlands, 1994, ISBN 0-444-81695-x, 458 pp , 1995, Experimental Gerontology.
[11] L. Packer,et al. The Spin-Trap N-tert-α-Phenylbutylnitrone Prolongs the Life Span of the Senescence-Accelerated Mouse , 1995 .
[12] K. Meguro,et al. Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice , 1995, Pharmacology Biochemistry and Behavior.
[13] H. Tojo,et al. Dietary α-linolenate/linoleate balance influences learning and memory in the senescence-accelerated mouse (SAM) , 1995, Brain Research.
[14] T. Heya,et al. Effects of a sustained release formulation of thyrotropin-releasing hormone on behavioral abnormalities in senescence-accelerated mice. , 1994, European journal of pharmacology.
[15] M. Hosokawa,et al. Accelerated aging of dermal fibroblast-like cells from senescence-accelerated mouse (SAM). 1. Acceleration of population aging in vitro , 1994, Mechanisms of Ageing and Development.
[16] T. Yamamuro,et al. Effective intervention of low peak bone mass and bone modeling in the spontaneous murine model of senile osteoporosis, SAM-P/6, by Ca supplement and hormone treatment. , 1994, Bone.
[17] A. Shimada,et al. Genetic analysis of murine senile amyloidosis. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[18] K. Kitagawa,et al. Mouse senile amyloidosis , 1991, Virchows Archiv. B, Cell pathology including molecular pathology.
[19] K. Kitagawa,et al. Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis. , 1991, The Biochemical journal.
[20] M. Hosokawa,et al. Senescence‐Accelerated Mouse (SAM): A Novel Murine Model of Accelerated Senescence , 1991, Journal of the American Geriatrics Society.
[21] K. Higuchi,et al. Kinetic analysis of amyloid fibril polymerization in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[22] Y. Kitamura,et al. Effects of bifemelane hydrochloride, a brain function improver, on muscarinic receptors in the CNS of senescence-accelerated mouse. , 1991, Japanese journal of pharmacology.
[23] M. Hosokawa,et al. Effects of dietary restriction on age-related immune dysfunction in the senescence accelerated mouse (SAM). , 1990, The Journal of nutrition.
[24] M. Sasaki,et al. Acceleration of chromosome aberrations in senescence-accelerated strains of mice. , 1990, Mutation research.
[25] P. Anthony. Robbins' Pathologic Basis of Disease , 1990 .
[26] T. Yamamuro,et al. Decreased endosteal formation during cortical bone modelling in SAM-P/6 mice with a low peak bone mass. , 1989, Bone and mineral.
[27] T. Iizuka,et al. Age-related changes in the temporomandibular joint of the senescence accelerated mouse. SAM-P/3 as a new murine model of degenerative joint disease. , 1989, The American journal of pathology.
[28] M. Hosokawa,et al. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.
[29] K. Higuchi,et al. A molecular-pathologic approach to murine senile amyloidosis. Serum precursor-apolipoprotein A-II variant (Pro5----Gln) presents only in the senile amyloidosis-prone SAM-P/1 and SAM-P/2 mice. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[30] M. Hosokawa,et al. Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum. apoSASSAM is an apoA-II apolipoprotein of mouse high density lipoproteins. , 1986, The Journal of biological chemistry.
[31] K. Higuchi,et al. High homology is present in the primary structures between murine senile amyloid protein (ASSAM) and human apolipoprotein A‐II , 1986, FEBS letters.
[32] S. Aota,et al. Molecular cloning and nucleotide sequence of cDNA for murine senile amyloid protein: nucleotide substitutions found in apolipoprotein A-II cDNA of senescence accelerated mouse (SAM). , 1986, Nucleic acids research.
[33] M. Hosokawa,et al. Chronic food restriction modulates the advance of senescence in the senescence accelerated mouse (SAM). , 1985, The Journal of nutrition.
[34] M. Hosokawa,et al. Grading score system: A method for evaluation of the degree of senescence in Senescence Accelerated Mouse (SAM) , 1984, Mechanisms of Ageing and Development.
[35] L. Melton,et al. Evidence for two distinct syndromes of involutional osteoporosis. , 1983, The American journal of medicine.
[36] M. Hosokawa,et al. Systemic senile amyloid in senescence-accelerated mice. A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[37] Keiichi Higuchi,et al. Spontaneous age-associated amyloidosis in senescence-accelerated mouse (SAM) , 1982, Mechanisms of Ageing and Development.
[38] M. Hosokawa,et al. A novel amyloid fibril protein isolated from senescence-accelerated mice. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[39] Keiichi Higuchi,et al. A new murine model of accelerated senescence , 1981, Mechanisms of Ageing and Development.
[40] W. Brown,et al. Hereditary premature sensescence of the rabbit. I. Chronic form; general features. , 1960, The Journal of experimental medicine.
[41] W. Brown,et al. Hereditary premature senescence of the rabbit. II. Acute form; general features. , 1960 .
[42] M. Hosokawa,et al. Accelerated aging of dermal fibroblast-like cells from the senescence-accelerated mouse (SAM): acceleration of changes in DNA ploidy associated with in vitro cellular aging. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.
[43] M. Hosokawa,et al. Senescence-accelerated Mouse (SAM): With Special Reference to Development and Pathological Phenotypes. , 1997, ILAR journal.
[44] Ulrich Mohr,et al. Pathobiology of the aging mouse , 1996 .
[45] H. Kimura,et al. Acidic fibroblast growth factor protects memory and immunoreactivity impairment in senescence accelerated mice. , 1995, Neurobiology.
[46] K. Higuchi,et al. Molecular genetic characterization of the senescence-accelerated mouse (SAM) strains. , 1994, Journal of gerontology.
[47] T. Takeda. Senescence-Accelerated Mouse (SAM). A novel murine model of aging , 1994 .
[48] E. Masoro. Animal Models in Aging Research , 1990 .
[49] A. Awaya,et al. Effects of repeated administrations of facteur thymique sérique (FTS) on biochemical changes related to aging in senescence-accelerated mouse (SAM). , 1990, Japanese journal of pharmacology.
[50] K. Yagi,et al. Lipid Peroxide Levels in the Skin of the Senescence-Accelerated Mouse , 1988 .
[51] 松下 睦. Age-related changes in bone mass in the senescence-accelerated mouse (SAM) : SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis , 1987 .
[52] M. Hosokawa,et al. Purification and Characterization of a Senile Amyloid-related Antigenic Substance (apoSASsAM) from Mouse Serum , 1986 .
[53] Popp Dm. Use of congenic mice to study the genetic basis of degenerative disease. , 1978 .